PRL and breast cancer: However, the growing evidence supporting an association between prolactin-increasing antipsychotics and long-term events, such as fragility fractures14 and breast cancer,24,31 and the plausibility of a biological mechanism between increased breast cancer risk and prolactin elevation,20,21 also calls for caution in prescribing prolactin-increasing antipsychotics to women.